Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Pressure BioSciences's
Operating Income
for the
three
months ended in Jun. 2024 was $-1.93 Mil. Pressure BioSciences's Interest Expense for the
three
months ended in Jun. 2024 was $-3.54 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Pressure BioSciences's Interest Coverage or its related term are showing as below:
PBIO's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.03 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Pressure BioSciences Interest Coverage Related Terms
Pressure BioSciences Interest Coverage Historical Data
* Premium members only.
The historical data trend for Pressure BioSciences's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
PBIO vs EMED, CUTRQ, MHTX: Interest Coverage Comparison
For the Medical Devices subindustry, Pressure BioSciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pressure BioSciences Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Pressure BioSciences's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Pressure BioSciences did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Pressure BioSciences (PBIO) has a Interest Coverage of 0 (At Loss) as of Jun. 2024. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pressure BioSciences and its competitors.
Is Pressure BioSciences' Interest Coverage too high?
Pressure BioSciences' current Interest Coverage is 0 (At Loss). Overall, Pressure BioSciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pressure BioSciences' Interest Coverage compare to EMED and CUTRQ?
Pressure BioSciences' Interest Coverage of 0 (At Loss) can be compared against companies in the Medical Devices & Instruments industry. The industry median Interest Coverage is 16.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.03, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pressure BioSciences and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pressure BioSciences's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pressure BioSciences stock overvalued right now?
Pressure BioSciences (PBIO) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Pressure BioSciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Pressure BioSciences (PBIO), the current Interest Coverage is 0 (At Loss) as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
12GF Score
Get the complete analysis for PBIO
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBIO has been successfully added to your 
